Adicet Bio, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold ACET, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
10
Funds holding
$5665810
Total value held
Buying
6 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Franklin Resources Inc | $4266949 | 626571 | — | Held |
| 2 | Regeneron Pharmaceuticals, Inc. | $412080 | 60511 | — | Held |
| 3 | Blackrock, Inc. | $249144 | 36585 | — | Held |
| 4 | State Street Corp | $246672 | 36222 | +10326 | +39.87% |
| 5 | Barclays Plc | $170250 | 25000 | — | NEW BUY |
| 6 | Johnson & Johnson | $155125 | 22779 | — | Held |
| 7 | Northern Trust Corp | $130752 | 19200 | +5133 | +36.49% |
| 8 | Morgan Stanley | $23787 | 3493 | +453 | +14.90% |
| 9 | Royal Bank Of Canada | $11000 | 1699 | — | NEW BUY |
| 10 | Amalgamated Financial Corp. | $51 | 2529 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.